Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
SVB Financial $2.25 billion concurrent offerings of notes and preferred stock
The company issued senior notes due 2026 and depositary shares representing Series D and Series E perpetual preferred stock
Synchrony Financial $750 million senior notes offering
The company issued investment-grade notes due 2031 in the SEC-registered offering
AngloGold Ashanti $750 million debt offering and cash tender offer
The company issued 3.375% notes due 2028 and offered to purchase its outstanding 5.125% notes due 2022
Bank of America $1.3 billion preferred stock offering
The company issued depositary shares, each representing an interest in its 4.25% non-cumulative preferred stock, Series QQ
Option Care Health $500 million notes offering
The company issued high-yield senior notes due 2029 in the Rule 144A / Regulation S offering
Kosmos Energy acquisition finance
We advised Kosmos on a multi-faceted acquisition financing
Enfusion $318.75 million IPO
We advised the underwriters on the IPO and NYSE listing
IVERIC bio $173.4 million stock offering
We advised the underwriters on the SEC-registered equity offering
Morgan Stanley $1.3 billion preferred stock offering
We advised Morgan Stanley on its SEC-registered offering
Pegasus Digital Mobility Acquisition $200 million IPO
We advised the underwriters on the SPAC IPO and NYSE listing